-transparent.png){kind=logo}
We investigated the possible role of type-1 plasminogen activator inhibitor (PAI-1) on success or failure of thrombolytic therapy with recombinant tissue plasminogen activator (rt-PA) in 10 responders and 10 non-responders with acute myocardial infarction and early initiation of therapy within 2 h of onset using the common infusion scheme (100 mg rt-PA over 3 h). We determined plasma levels of t-PA (activity and antigen) as well as PAI-1 (activity and antigen) in samples obtained before, during and after thrombolytic treatment and compared the course of each of those parameters between responders and non-responders to therapy. Success or failure of treatment was determined by a combination of noninvasive methods and proven by coronary angiography within 5 days of initiation of thrombolysis. Thirty, 60, 90, and 120 min after initiation of rt-PA infusion, specific t-PA activities in plasma of responders were 0.62, 0.63, 0.62, and 0.57 (IU/ng/ml), respectively, as compared to 0.42, 0.42, 0.40, and 0.32 (IU/ng/ml) in nonresponders (p < 0.001). Between 4 and 8 h after initiation of therapy, a time span known to be critical for thrombotic reocclusion, specific activities were still significantly elevated in responders as compared to non-responders (p < 0.01). PAI-1 activity levels, which were not detectable during rt-PA infusion in either group, recovered to pre-treatment values 2 h earlier in non-responders.(ABSTRACT TRUNCATED AT 250 WORDS)
K Huber, and
R Beckmann, and
F Rauscha, and
P Probst, and
F Kaindl, and
B R Binder
March 1991,
Bollettino chimico farmaceutico,
K Huber, and
R Beckmann, and
F Rauscha, and
P Probst, and
F Kaindl, and
B R Binder
July 1994,
Nihon rinsho. Japanese journal of clinical medicine,
K Huber, and
R Beckmann, and
F Rauscha, and
P Probst, and
F Kaindl, and
B R Binder
January 2001,
Seminars in thrombosis and hemostasis,
K Huber, and
R Beckmann, and
F Rauscha, and
P Probst, and
F Kaindl, and
B R Binder
August 1987,
Radiology,
K Huber, and
R Beckmann, and
F Rauscha, and
P Probst, and
F Kaindl, and
B R Binder
April 1988,
Thrombosis research,
K Huber, and
R Beckmann, and
F Rauscha, and
P Probst, and
F Kaindl, and
B R Binder
June 1990,
Neurological research,
K Huber, and
R Beckmann, and
F Rauscha, and
P Probst, and
F Kaindl, and
B R Binder
August 1991,
Geburtshilfe und Frauenheilkunde,
K Huber, and
R Beckmann, and
F Rauscha, and
P Probst, and
F Kaindl, and
B R Binder
January 1988,
Seminars in thrombosis and hemostasis,
K Huber, and
R Beckmann, and
F Rauscha, and
P Probst, and
F Kaindl, and
B R Binder
March 1990,
Circulation,
K Huber, and
R Beckmann, and
F Rauscha, and
P Probst, and
F Kaindl, and
B R Binder
March 1991,
The Journal of biological chemistry,
